awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37141627-78A3735E-7F12-46DB-B6C5-6083971CC0AD
Q37141627-78A3735E-7F12-46DB-B6C5-6083971CC0AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37141627-78A3735E-7F12-46DB-B6C5-6083971CC0AD
An optimized antibody-single-chain TRAIL fusion protein for cancer therapy.
P2860
Q37141627-78A3735E-7F12-46DB-B6C5-6083971CC0AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37141627-78A3735E-7F12-46DB-B6C5-6083971CC0AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1b36f6f3a4dbe1c6d301a9ff70349a499beab54
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.